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Virilizing Adrenocortical Oncocytoma in a Child: A Case Report
Functioning adrenocortical oncocytomas are extremely rare and most reported patients are 
40-60 yr of age. To our knowledge, only 2 cases of functioning adrenocortical oncocytomas 
have been reported in childhood. We report a case of functioning adrenocortical 
oncocytoma in a 14-yr-old female child presenting with virilization. She presented with 
deepening of the voice and excessive hair growth, and elevation of plasma testosterone 
and dehydroepiandrosterone sulfate. She had an adrenalectomy. The completely resected 
tumor composed predominantly of oncocytes without atypical mitosis and necrosis. A 
discussion of this case and a review of the literature on this entity are presented.
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CASE REPORT
Oncology & Hematology
INTRODUCTION
An oncocytoma is a tumor that is composed predominantly of 
polygonal oncocytes with abundant granular and intensely eo-
sinophilic cytoplasm. It occurs in virtually every organ, most 
commonly the kidney, salivary glands, and thyroid. An oncocy-
toma that arises in the adrenal gland is very rare and usually be-
nign and nonfunctioning. Because of the unusual occurrence 
of functioning adrenocortical oncocytoma, particularly in child-
hood, we report here a case of adrenocortical oncocytoma in a 
girl presenting with virilization. We also discuss this case and 
review the literature in terms of pathologic classification and 
malignant potential.
CASE REPORT
A 14-yr-old girl presented with deepening of the voice and exces-
sive hair growth as well as change in body habitus since about  
1 yr prior to admission. She was born at full term without peri-
natal problems and had no special health problems previously. 
Her mother worried about not only her hypertrichosis but also 
her lack of menarche. Her body weight was 69.5 kg (95-97 per-
centile), height was 165.1 cm (90-95 percentile) and body mass 
index was 25.5 kg/m
2. Her blood pressure was normal. Physical 
examination revealed acne on the face and a male pattern of 
excessive hair on the chin, anterior chest wall, lower abdomen 
and inner thigh (Fig. 1). A huge, hard mass was palpated on the 
right abdomen. Her breast was Tanner stage 2, but her bone age 
(17 yr) was advanced. She had mild clitomegaly. We performed 
a hormonal study for evaluation of virilization, which revealed 
increased plasma testosterone (>1,500 ng/dL, reference range: 
≤32 ng/dL) and dehydroepiandrosterone sulfate (DHEA-S) 
(>1,000 µg/dL, reference range: ≤260 µg/dL) levels. Plasma 17- 
hydroxyprogesterone (17-OHP) was also increased (56.4 ng/mL, 
reference range: ≤2.3 ng/mL). Plasma adrenocorticotrophic hor-
mone (ACTH) was 5.1 pg/mL (reference range: 5-37 pg/mL) and 
plasma cortisol was 26.7 µg/dL (reference range: 4-11 µg/dL). 
Plasma lutenizing hormone (LH) was 0.24 mIU/mL and plas-
ma follicle-stimulating hormone (FSH) was <0.1 mIU/mL. The 
abdominal computed tomography (CT) scan and magnetic res-
onance imaging (MRI) showed a 12×12×14 cm-sized, well-cir-
cumscribed, huge mass which displaced the right kidney an-
teromedially (Fig. 2). The positron emission tomography (PET) 
CT scan revealed a heterogeneous hypermetabolic mass only 
in the area between the liver and right kidney, which suggested 
a malignant retroperitoneal or adrenal tumor (Fig. 3). A whole 
body bone scan found no active lesions. We performed a low 
dose (0.5 mg q 6 hr for 48 hr) and high dose (2 mg q 6 hr for 48 
hr) dexamethasone suppression test and the result of that was 
not compatible with Cushing’s syndrome. She had a right adre-
nalectomy and her postoperative course was uneventful. The 
resected tumor was a huge encapsulated round mass, measur-Lim Y-J, et al.  •  Virilizing Adrenocortical Oncocytoma in a Child
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ing 17.5×15×14 cm in dimension and 1,100 gm in weight. The 
outer surface was smooth and glistening (Fig. 4). Microscopi-
cally (Fig. 5), the tumor was composed of large cells with eosin-
ophilic cytoplasm. Capsular or sinusoidal invasion was not not-
ed and the subcapsular area showed a compressed normal ad-
renal cortex. Atypical mitosis and necrosis were absent. These 
findings were compatible with the diagnosis of oncocytoma. At 
2 weeks after removal of the adrenal tumor, her serum testoster-
one and DHEA level decreased dramatically to normal ranges, 
respectively.
DISCUSSION
Virilization in an adolescent or woman can manifest as clitoral 
enlargement, increased muscle strength, acne, hirsutism, fron-
tal hair thinning, deepening of the voice, and menstrual disrup-
tion due to anovulation. Some of the possible causes of viriliza-
tion in women are polycystic ovary syndrome, androgen-pro-
ducing tumors (of the ovaries, adrenal glands, pituitary gland), 
hypothyroidism, anabolic steroid exposure, congenital adrenal 
hyperplasia due to 21-hydroxylase deficiency (late-onset), and 
hormone replacement therapy (female-to-male) (1). 
  Adrenocortical neoplasms are rare in children and adoles-
cents. Tumors account for less than 0.2% of all pediatric neo-
plasms and 1.3% of all carcinomas in patients less than 20-yr-
old (2). Single tumors usually are benign unilateral adenomas 
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Fig. 1. Excessive hair pattern: (A) chin, (B) lower abdomen.
Fig. 2. An abdominal computed tomography (CT) scan showed a 12×12×14 cm-sized, 
well-circumscribed, huge mass which displace the right kidney anteromedially.
Fig. 3. The positron emission tomography (PET) CT scan revealed a heterogeneous 
hypermetabolic mass which suggested a malignant retroperitoneal or adrenal tumor.
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Fig. 4. Gross findings of resected tumor. (A) Well-demarcated huge mass, (B) Cut 
surface of resected tumor showing smooth and glistening surface.
Fig. 5. Microscopic findings of resected tumor. (A) The tumor was composed of large 
cells with eosinophilic cytoplasm. The capsular or sinusoidal invasion was not noted and 
the subcapsular area showed a compressed normal adrenal cortex. (B) Atypical mitosis 
and necrosis were absent (H&E, A ×100, B ×400). 
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and more rarely malignant carcinomas. Adrenocortical tumors 
can be either functional or non-functional. In children, most tu-
mors are functional, with 80-90% having endocrine manifesta-
tions at diagnosis and up to 94% secreting excess hormones on 
further evaluation (3). Most children (50-84%) present with vir-
ilization (pubic hair, accelerated growth and skeletal maturation, 
an enlarged penis or clitoris, hirsutism and acne) due to excess 
androgen secretion.
  The adrenocortical oncocytoma is extremely rarely found; 
only renal oncocytoma is commonly reported in children (4). 
Only a little more than 50 cases of adrenal oncocytoma have 
been reported in the literature (5). They were usually benign and 
nonfunctioning. The functioning adrenocortical oncocytomas 
have been reported so far in only 9 cases, of whom 7 patients 
were 40-60 yr of age and only 2 patients were 6 and 12 yr of age. 
The reported 2 children presented with virilization and pseudo-
puberty, and our patient also presented with virilization show-
ing high serum testosterone and DHEA levels. 
  The major practical problem for our case was to differentiate 
benign from malignant adrenocortical oncocytoma after com-
plete resection of the tumor. We considered her tumor as bor-
derline because only one minor criterion was fulfilled accord-
ing to the malignancy scoring system proposed by Bisceglia (6). 
As Juliano et al. reported a case of metastatic adrenocortical on-
cocytoma (7), we tried a metastatic work-up including a whole 
body bone scan, chest CT scan and PET-CT scan, which reveal–
ed negative findings. Based on the borderline criteria of patho-
logic classification and no metastatic evidence, we decided to 
just observe her without further post-operative chemoradio-
therapy. However, she is being monitored by a physical exami-
nation and abdominal CT scan biannually for 2 yr, then annu-
ally for the next 5 yr.
  In conclusion, we report a very rare case of virilizing adreno-
cortical oncocytoma, particularly in a female child. Although 
the malignant potential of this tumor is feeble and controversial, 
we must pay attention to recurrences because little is known of 
the tumor’s long-term natural history.
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